NKTR

NKTR

NKTR

Market Cap: $2.04B

Letters With This Ticker

Quarter Letter Date Fund Name QTD YTD Tickers Keywords/Themes Theme Commentary Pitches Letter
2026 Q1 Apr 10, 2026 Cedar Grove Capital Management -23.0% -23.0% ABVX, EVLV, HIMS, KITS.TO, LNSR, MTY.TO, NKTR, OSW, REAL, SNWV, TOI, WW Biotechnology, consumer, healthcare, Long/Short, Multi-Strategy, small cap, special situations MTY.TO
NKTR
ABVX
TOI
SNWV
EVLV
REAL
KITS.TO

Pitches With This Ticker

Date Pitch Type Author Company Industry Sub Industry Bull / Bear Stock Exchange Keywords Action
Apr 23, 2026 Fund Letters Cedar Grove Capital Management Nektar Therapeutics Biotechnology Biotechnology Bull NASDAQ acquisition target, Atopic Dermatitis, biotechnology, JAK Inhibitors, Phase 3, Quarterly Dosing, safety profile, Special situations
Jan 23, 2026 Twitter / X @A_May_MD Nektar Therapeutics Health Care Biotechnology Bull NASDAQ cybersecurity, Easi, Easi Reduction, Mean Easi, Nktr, Pbo Adj, Photonics, Week
Jan 22, 2026 Twitter / X @seedy19tron Nektar Therapeutics Health Care Biotechnology Bull NASDAQ ATD, consumer lending, Efficacy, Immuno-oncology, Nktr, Payments, Rezpeg, Satellite

BSD Shareholders of NKTR

This report provides a detailed summary of investor holdings for a specified stock ticker, highlighting key metrics such as fund name, total assets under management (AUM), invested value, portfolio weight, and shares owned. It also tracks changes in share ownership during the last quarter, including the percentage of shares bought or sold and the percentage of outstanding shares owned. The data is generated using an API that processes investor holdings and calculates these values for each fund. This report helps investors and analysts monitor the stock positions of major funds, identify investment trends, and assess the influence of large investors on individual stocks.

Filing Date: September 30, 2025
Manager Name Fund Name Fund AUM Invested Value Portfolio Weight Shares Owned Shares Bought / Sold During Quarter % Bought / Sold During Quarter % of Shares Outstanding Owned
Neil Kumar Ikarian Capital $1.2B $1.5M 0.12% 36,300 +36,300 +100.00% 0.0753%
Steven A. Cohen Point72 Asset Management $86.8B $18.3M 0.02% 433,419 -23,500 -72.31% 0.8994%
Dmitry Balyasny Balyasny Asset Management $76.6B $11.9M 0.02% 282,021 +99,207 +54.27% 0.5852%
Israel Englander Millennium Management LLC $233.2B $19.2M 0.01% 454,075 -91,919 -16.84% 0.9423%
David Siegel & John Overdeck Two Sigma Investments $67.5B $20.0M 0.03% 473,014 +38,777 +8.93% 0.9816%
Rich Handler Jefferies $19.3B $4.7M 0.02% 111,900 -191,300 -63.09% 0.2322%

Join for free and get access to the buyside

Get insights from the world's most influential hedge fund investors direct to your inbox

join for free
buysidedigest hedge fund letters for investors

Follow Us On: